Koyfin Home > Directory > Health Care > Amicus Therapeutics > EV / Sales (ltm)

Amicus Therapeutics EV / Sales (ltm) Chart (FOLD)

Amicus Therapeutics annual/quarterly EV / Sales (ltm) from 2008 to 2018.
  • Amicus Therapeutics EV / Sales (ltm) for the quarter ending March 03, 2018 was 70.86 a -103.52% decrease of -73.35 year over year
  • Amicus Therapeutics Annual EV / Sales (ltm) for 2017 was 85.60 a -208.12% decrease of -178.15 from 2016
  • Amicus Therapeutics Annual EV / Sales (ltm) for 2016 was 263.75 a 99.57% increase of 262.60 from 2015
  • Amicus Therapeutics Annual EV / Sales (ltm) for 2012 was 1.14 a -167.52% decrease of -1.91 from 2011
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
View Chart On Koyfin

Quarterly FOLD EV / Sales (ltm) Data

03/201870.86
12/201785.60
09/2017148.21
06/2017144.21
03/2017169.85
12/2016263.75
06/2014192.50
03/2014169.03
06/20132.96
03/20133.20

Annual FOLD EV / Sales (ltm) Data

201785.60
2016263.75
20121.14
20113.05
20101.52
20090.25
20083.67